Skip to main content
FCHS
OTC Industrial Applications And Services

First Choice Healthcare Reports $8.4M Loss, Going Concern Doubt, and Details of SPAC Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
9
Price
$0.008
Mkt Cap
$273.554K
52W Low
$0.002
52W High
$0.51
52W Position info
453% above low
Off High info
98% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

FCHS has more than doubled off its 52-week low of $0.002 on light trading volume (0.1× avg).

Summary

First Choice Healthcare's 10-Q shows deepening losses, a near-zero cash balance, and a going concern warning, while also revealing the terms of a debt-to-equity conversion and the full acquisition agreement for its SPAC merger.


Key Events · Earnings and Guidance · FCHS

  • Net Loss Widens to $8.4M

    For the six months ended June 30, 2026, net loss attributable to common shareholders was $8,447,243, compared to $2,037,329 in the prior year period, driven by a $7.4 million interest expense from debt conversions.

  • Going Concern Warning

    The company states substantial doubt about its ability to continue as a going concern, with a working capital deficit and cash of only $6,842 as of June 30, 2026.

  • Debt Converted to Preferred Stock

    $22,242,837 of debt was converted into Series C Preferred Stock, and Series E Preferred Stock was issued with a 15% dividend and a conversion price at a 20% discount to the lowest closing price after 12 months, creating significant future dilution risk.

  • SPAC Merger Details Disclosed

    The 10-Q includes the Amended and Restated Stock Purchase Agreement for the acquisition of Pointe Med Entities, with a maximum purchase price of $21,306,000, to be completed concurrently with the Westin Acquisition Corp. business combination.


Analysis · FCHS · Industrial Applications And Services

The 10-Q reveals a net loss of $8.4 million for the first half of 2026, a cash balance of just $6,842, and a going concern warning. It also details the conversion of $22.2 million of debt into preferred stock with highly dilutive terms, including a 20% discount conversion price for Series E. The filing includes the full acquisition agreement for the Pointe Med Entities, valued at $21.3 million, which is part of the previously announced SPAC merger. These details materially change the risk profile for existing shareholders.

At the time of this filing, FCHS was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $273.6K. The 52-week trading range was $0.00 to $0.51. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FCHS - Latest Insights

FCHS
Jul 28, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
9
FCHS
Apr 14, 2026, 1:41 PM EDT
Filing Type: S-1/A
Importance Score:
9
FCHS
Mar 27, 2026, 3:12 PM EDT
Filing Type: S-1/A
Importance Score:
9
FCHS
Mar 11, 2026, 4:15 PM EDT
Filing Type: 10-K
Importance Score:
9